Myaln Files Request To List On Tel Aviv Stock Exchange

October 12, 2015 | Dutch drug-maker Mylan formally filed a request to list on the Tel Aviv Stock Exchange (TASE) as part of the company’s ongoing hostile bid for the Irish pharmaceutical Perrigo, which also trades on the TASE. Israeli pharma companies made M&A headlines earlier this year when Teva pursued a hostile takeover of Mylan, and in order to fend off the bid, Mylan pursued its own hostile takeover of Perrigo. Teva has since abandoned its bid in favor of Allergan’s generic drug business. However, Mylan has stayed its course and become engrossed in a legal battle, in which both Mylan and Perrigo have filed suits regarding share purchases in US district courts.